Barry D. Quart
Overview
Barry D. Quart received an average of $5M in total compensation, including $559K in salary, at Heron Therapeutics from 2013 to 2023.
2023Heron TherapeuticsFormer Chief Executive Officer
2022Heron TherapeuticsFormer Chief Executive Officer
2021Heron TherapeuticsChief Executive Officer
2020Heron TherapeuticsChief Executive Officer
2019Heron TherapeuticsPresident and Chief Executive Officer
2018Heron TherapeuticsPresident and Chief Executive Officer
2017Heron TherapeuticsPresident and Chief Executive Officer
2015Heron TherapeuticsChief Executive Officer
2014Heron TherapeuticsChief Executive Officer
2013Heron TherapeuticsChief Executive Officer
Source: SEC filings on April 29, 2024, May 1, 2023, April 25, 2022, April 22, 2021, April 23, 2020, and April 29, 2016.
Related executives
We found 22 more executives who work or worked at Heron Therapeutics.
Craig Collard
Heron Therapeutics
Chief Executive Officer
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
Ira Duarte
Heron Therapeutics
Chief Financial Officer
William Forbes
Heron Therapeutics
Chief Development Officer
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
News
Heron Therapeutics CEO Craig Collard receives $11M in 2023
April 29, 2024
Heron Therapeutics Executive Vice President, Drug Development Kimberly Manhard's 2022 pay falls 22% to $1.4M
May 1, 2023
Heron Therapeutics CEO Barry Quart's 2021 pay rises 2% to $5.4M
April 25, 2022
Heron Therapeutics CEO Barry Quart's 2020 pay slips 9% to $5.3M
April 22, 2021
Heron Therapeutics CEO Barry Quart's 2019 pay slips 2% to $5.9M
April 23, 2020